![conference banner](/images/conference-banner.jpeg)
Abstract
This review focuses on the recent developments and future trends dealing with its modifications, encompassing the different grades of polymethacrylates polymers based formulations. The last three decades of pioneering works explain it as a new functional material of high potential value in novel drug delivery. Polymethacrylates are synthetic cationic and anionic copolymers of dimethylaminoethyl methacrylates, methacrylic acid, and methacrylic acid esters in varying ratios, generating a new and modified patterned polymer due to their electrical characters and pH- dependent solubility. Based on current research and existing products, some new and futuristic approaches in this fascinating area have been thoroughly explored and discussed. These polymers are used as release retardant in different formulations like oral capsules and tablets, film-coating agents for protective purposes and provide sustained release formulations. This review also screens the current applications of these polymers in the development of microparticles, patches, nanoparticles, colon targeted formulations, ophthalmic, vaccine delivery, taste masking agent and its pivotal application in gene delivery systems. This work summarizes the achievements of past which can be extrapolated to characterize the possible array of polymeric interactions, exploiting their desirable properties for future studies.
Keywords: Applications, polymethacrylates, review
Current Drug Therapy
Title:Applicability and Approaches of (Meth) Acrylate Copolymers (Eudragits) in Novel Drug Delivery Systems
Volume: 7 Issue: 4
Author(s): Kumar Animesh, Moin Afrasim, Rami R. Bommareddy, Ahmed Ayaz, Ravi Shruthi and Hoskote G. Shivakumar
Affiliation:
Keywords: Applications, polymethacrylates, review
Abstract: This review focuses on the recent developments and future trends dealing with its modifications, encompassing the different grades of polymethacrylates polymers based formulations. The last three decades of pioneering works explain it as a new functional material of high potential value in novel drug delivery. Polymethacrylates are synthetic cationic and anionic copolymers of dimethylaminoethyl methacrylates, methacrylic acid, and methacrylic acid esters in varying ratios, generating a new and modified patterned polymer due to their electrical characters and pH- dependent solubility. Based on current research and existing products, some new and futuristic approaches in this fascinating area have been thoroughly explored and discussed. These polymers are used as release retardant in different formulations like oral capsules and tablets, film-coating agents for protective purposes and provide sustained release formulations. This review also screens the current applications of these polymers in the development of microparticles, patches, nanoparticles, colon targeted formulations, ophthalmic, vaccine delivery, taste masking agent and its pivotal application in gene delivery systems. This work summarizes the achievements of past which can be extrapolated to characterize the possible array of polymeric interactions, exploiting their desirable properties for future studies.
Export Options
About this article
Cite this article as:
Animesh Kumar, Afrasim Moin, R. Bommareddy Rami, Ayaz Ahmed, Shruthi Ravi and G. Shivakumar Hoskote, Applicability and Approaches of (Meth) Acrylate Copolymers (Eudragits) in Novel Drug Delivery Systems, Current Drug Therapy 2012; 7 (4) . https://dx.doi.org/10.2174/157488512804999082
DOI https://dx.doi.org/10.2174/157488512804999082 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
BUB1B Promotes Proliferation of Prostate Cancer via Transcriptional Regulation of MELK
Anti-Cancer Agents in Medicinal Chemistry Prognostic Factors after R0 Resection of Colorectal Cancer Liver Metastases: A Systematic Review and Pooled-Analysis
Reviews on Recent Clinical Trials Angiogenic Growth Factors and their Inhibitors in Diabetic Retinopathy
Current Diabetes Reviews Do We Have Another Option to Treat Bleeding Hemorrhoids? The Emborrhoid Technique: Experience in 16 Patients
Reviews on Recent Clinical Trials Aldose Reductase Enzyme and its Implication to Major Health Problems of the 21st Century
Current Medicinal Chemistry Pharmacological Control of Autophagy: Therapeutic Perspectives in Inflammatory Bowel Disease and Colorectal Cancer
Current Pharmaceutical Design Vesicovaginal Fistula
Current Women`s Health Reviews Targeted Therapy Options for Treatment of Bone Metastases; Beyond Bisphosphonates
Current Pharmaceutical Design MicroRNA Regulation of Androgen Receptor in Castration-Resistant Prostate Cancer: Premises, Promises, and Potentials
Current Molecular Pharmacology A Rationale for the Use of Proton Pump Inhibitors as Antineoplastic Agents
Current Pharmaceutical Design Marine Originated Fused Heterocyclic: Prospective Bioactivity against Cancer
Current Traditional Medicine Myc - What We have Learned from Flies
Current Drug Targets TRIM65 in White Matter Lesions, Innate Immunity, and Tumor
Current Molecular Pharmacology Antifolates - Past, Present and Future
Current Medicinal Chemistry - Anti-Cancer Agents SUBJECT INDEX TO VOLUME 1
Current Genomics Hybridized Quinoline Derivatives as Anticancer Agents: Design, Synthesis, Biological Evaluation and Molecular Docking
Anti-Cancer Agents in Medicinal Chemistry JAK Inhibitors: Pharmacology and Clinical Activity in Chronic Myeloprolipherative Neoplasms
Current Medicinal Chemistry Hormone Replacement Therapy and Stroke
Current Vascular Pharmacology Cancer Therapy Through Control of Cell Migration
Current Cancer Drug Targets Inhibition of Procarcinogen Activating Enzyme CYP1A2 Activity and Free Radical Formation by Caffeic Acid and its Amide Analogues
Drug Metabolism Letters